【レポートの概要（一部）】
1. Report Overview
1.1 The Alzheimer’s Disease Therapeutics and Diagnostics Market Overview
1.2 The Alzheimer’s Disease Therapeutics and Diagnostics Market Segmentation
1.3 Why You Should Read This Report
1.4 How This Report Delivers
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report For?
1.7 Methodology
1.8 Frequently Asked Questions (FAQ)
1.9 Associated Reports
1.10 About Visiongain
2. Alzheimer’s Disease: An Introduction
2.1 Neurodegenerative Diseases
2.1.1 What is Alzheimer’s Disease?
2.1.2 What Causes Alzheimer’s Disease?
2.1.2.1 Alzheimer’s Disease: Type 3 Diabetes?
2.1.3 Management of Alzheimer’s Disease
2.1.4 The Socio-Economic Impact of Alzheimer’s Disease
2.1.5 Diagnosis of Alzheimer’s Disease
3. Alzheimer’s Disease Therapeutics and Diagnostics Market 2016-2026
3.1 Alzheimer’s Disease Therapeutics and Diagnostics Market, 2015
3.2 Alzheimer’s Disease Therapeutics and Diagnostics Market Forecast, 2015-2026
3.2.1 The Market Has Been Left Exposed to Intensified Generic Competition
3.2.2 Healthcare Costs for Alzheimer’s Disease Will Surpass All Other Medical Expenses
3.2.3 New Diagnostics and Drugs Regulatory Guidelines Will Lower the Barriers to Entry
3.3 Drivers and Restraints
4. The Alzheimer’s Disease Drugs Market, 2016-2026
4.1 Current Approaches and Unmet Needs in the Treatment of Alzheimer’s disease
4.2 The Alzheimer’s Disease Drugs Market, 2015
4.3 Changing Market Shares of the Leading Alzheimer’s Disease Drugs, 2016-2026
4.4 The Alzheimer’s Disease Drugs Market Forecast 2016-2026
4.5 Namenda
4.5.1 Namenda Sales Forecast, 2016-2026
4.6 Aricept
4.6.1 Aricept Sales Forecast, 2016-2026
4.7 Exelon
4.7.1 Exelon Sales Forecast, 2016-2026
4.8 Alzheimer’s Disease Drugs Pipeline, 2015
4.8.1 New Guidelines: FDA to Relax Rules for the Approval of Alzheimer’s Drugs
4.8.2 Will Novel Drug Development Strategies Prove Successful?
4.8.3 Solanezumab (Eli Lilly)
4.8.3.1 Solanezumab Sales Forecast 2016-2026
4.8.4 Gantenerumab (Roche)
4.8.4.1 Gantenerumab Pipeline Forecast, 2015-2026
4.8.5 MK-8931 (Merck)
4.8.5.1 The MK-8931 Pipeline Forecast, 2015-2026
4.8.6 Lu AE58054 (Lundbeck)
4.8.7 TTP488 (TransTechPharma)
4.8.8 LMTX (TauRx)
4.8.9 EVP-6124 (Forum Pharmaceuticals)
4.8.10 Axona (Accera)
4.8.11 AD-4833 (Takeda Pharmaceuticals)
4.9 Deep Brain Stimulation (Functional Neuromodulation)
4.10 Recent Research on Alzheimer’s Disease
5. Leading Companies in the Alzheimer’s Disease Drugs Market, 2015
5.1 Pfizer, Inc
5.1.1 Sales and Recent Performance Analysis, 2015
5.1.2 Pfizer: Aricept
5.1.3 Pfizer: R&D Capabilities and Alzheimer’s Disease Drug Candidates
5.2 Eisai
5.2.1 Sales and Recent Performance Analysis, 2015
5.2.2 Eisai: Aricept
5.2.3 Eisai: R&D Capabilities and Alzheimer’s Disease Drug Candidates
5.2.4 Collaboration with Biogen
5.2.5 Partnership with GE Healthcare for Diagnostic Development
5.3 Forest Laboratories (Acquired by Actavis)
5.3.1 Acquisition by Actavis
5.3.2 Forest: Namenda
5.3.3 Namenda’s Sales and Recent Performance Analysis, 2014
5.4 Lundbeck A/S
5.4.1 Sales and Recent Performance Analysis, 2014
5.4.2 Lundbeck: R&D Capabilities
5.4.3 Lundbeck’s Alzheimer’s Disease Drug Pipeline
5.4.4 Lundbeck: Ebixa
5.5 Daiichi Sankyo
5.5.1 Financial Sales and Recent Performance, 2015
5.5.2 Daiichi Sankyo: Memary
5.6 Novartis AG
5.6.1 Sales and Recent Performance Analysis
5.6.2 Novartis: Exelon
5.6.3 eHealth Programme Delivering Innovation
5.6.4 Novartis: Alzheimer’s Disease Drug Pipeline
5.7 TauRx
5.7.1 Partnership with Bayer Schering Pharma AG
5.8 vTv Therapeutics
5.8.1 TTP Translational Technology
5.8.2 vTv Therapeutics: Alzheimer’s Disease Pipeline Portfolio
6. The Alzheimer’s Disease Diagnostics Market, 2015-2026
6.1 There is Still a Strong Market Need for Effective Diagnosis
6.2 The Alzheimer’s Disease Diagnostics Market, 2015
6.3 Changing Market Shares of Leading Alzheimer’s Diagnostic Markets, 2015-2026
6.4 The Alzheimer’s Diagnostics Market, 2015-2026
6.5 New Criteria and Guidelines to Diagnose Alzheimer’s Disease
6.6 Biomarkers for Alzheimer’s Disease
6.6.1 Leading Companies Pursuing Novel Biomarker Development Strategies
6.7 Alzheimer’s Disease: Advances in Diagnostic Imaging Technologies
6.7.1 Structural Imaging
6.7.2 Functional Imaging
6.7.3 Molecular Imaging Technologies
6.7.3.1 Pittsburgh Compound B (PIB) (GE Healthcare)
6.7.3.2 Florbetapir F18 (18F-AV-45) (Eli Lilly)
6.7.3.3 Flutemetamol (GE Healthcare)
6.7.3.4 Florbetaben (Piramal Imaging)
6.8 Other Alzheimer’s Diagnostics in Development
6.8.1 CSF Proteins
6.8.2 Blood Based Biomarkers for Alzheimer’s Disease
6.8.3 Genetic Risk Profiling
6.8.4 Eye Tests
6.8.5 Nanoparticles
6.9 Leading Companies in the Alzheimer’s Disease Diagnostics Market, 2015
6.9.1 Eli Lilly
6.9.1.1 Recent Performance and Sales Analysis, 2015
6.9.1.2 Alzheimer’s Disease Research Effort
6.9.1.3 Solanezumab
6.9.1.4 Amyvid (Florbetapir F18)
6.9.1.5 Amyvid Receives Marketing Authorization from the European Commission
6.9.1.6 LY-2886721: Terminated Drug
6.9.1.7 LY3002813: Phase I
6.9.1.8 Eli Lilly Acquires Novel Tau Tangle Diagnostic Programme
6.9.2 Amarantus BioScience Holdings, Inc.
6.9.2.1 Recent Performance and Sales Analysis, 2014
6.9.2.2 LymPro
6.9.2.3 Intellectual Property Acquisitions
6.9.3 Piramal Enterprises
6.9.3.1 Piramal Imaging SA
6.9.3.2 U.S. and EMA Approval of Florbetaben
6.9.3.3 Manufacturing and Distribution Agreements
6.9.4 GE Healthcare
6.9.4.1 GE’s Commitment to Imaging Research in the Alzheimer’s Field
6.9.4.2 Regulatory Approval of Flutemetamol
6.9.4.3 Licensing Agreements for Flutemetamol
6.9.5 Navidea
6.9.5.1 NAV4694 (Fluorine-18)
6.9.5.2 Collaboration Agreements
6.9.5.3 NAV4694 Clinical Development
6.9.6 DiaGenic
7. The Leading National Markets, 2015-2026
7.1 Regional Breakdown of the Global Alzheimer’s Disease Therapeutics and Diagnostic Market, 2015
7.1.1 The US, Japan and Europe Represent More than 80% of the Total Market
7.2 The Global Alzheimer’s Disease Therapeutics and Diagnostics Market: Regional Forecast, 2015-2026
7.3 Changing Market Shares of Leading National Markets 2015-2026
7.4 The US Alzheimer’s Disease Therapeutics and Diagnostics Market, 2015-2026
7.4.1 One in Nine Over the Age of 65 has AD in the US
7.4.2 The US Will Remain the Largest Market Over the Forecast Period
7.5 The European Alzheimer’s Disease Therapeutics and Diagnostics Market, 2015-2026
7.5.1 The German Alzheimer’s Disease Therapeutics and Diagnostics Market Forecast, 2015-2026
7.5.2 The French Alzheimer’s Disease Therapeutics and Diagnostics Market Forecast, 2015-2026
7.5.3 The UK Alzheimer’s Disease Therapeutics and Diagnostics Market Forecast, 2015-2026
7.5.4 The Spanish Alzheimer’s Disease Therapeutics and Diagnostics Market Forecast, 2015-2026
7.5.5 The Italian Alzheimer’s Disease Therapeutics and Diagnostics Market Forecast, 2015-2026
7.5.6 The Rest of Europe Alzheimer’s Disease Therapeutics and Diagnostics Market Forecast, 2015-2026
7.6 The Japanese Alzheimer’s Disease Therapeutics and Diagnostics Market Forecast, 2015-2026
7.7 The Chinese Alzheimer’s Disease Therapeutics and Diagnostics Market Forecast, 2015-2026
7.8 The Indian Alzheimer’s Disease Therapeutics and Diagnostics Market Forecast, 2015-2026
7.9 The Brazilian Alzheimer’s Disease Therapeutics and Diagnostics Market Forecast, 2015-2026
7.10 The Russian Alzheimer’s Disease Therapeutics and Diagnostics Market Forecast, 2015-2026
7.11 The Rest of the World Alzheimer’s Disease Therapeutics and Diagnostics Market Forecast, 2015-2026
8. Qualitative Analysis of the Alzheimer’s Disease: Therapeutics and Diagnostics Market, 2016-2026
8.1 SWOT Analysis
8.2 Strengths
8.2.1 Alzheimer’s Disease is a High Profile Disease
8.2.2 Expanding Patient Population
8.2.3 Strong R&D Pipeline in Both Sectors of the Market
8.3 Weaknesses
8.3.1 Current Drugs Only Treat the Symptoms of Alzheimer’s Disease
8.3.2 Recent Failures of Promising Drug Candidates in Clinical Trials
8.3.3 Poor Macroeconomic Conditions in Key Regions of the Market
8.4. Opportunities
8.4.1 Regulations Seeking Improved Standards of Alzheimer’s Disease Drug Development
8.4.2 Neurodegenerative Diseases Have Strong R&D
8.4.3 Emerging Markets Will Help Drive the Market
8.4.4 Advances in Diagnostic Technologies Will Improve Drug Market Penetration
8.5 Threats
8.5.1 Patent Expiries Will Lead to Further Generic Competition
8.5.2 New AD Therapies Face Political, Commercial and Social Pressures
8.6 Porter’s Five Force Analysis
8.6.1 Rivalry Among Competitors
8.6.2 Threats of New Entrants
8.6.3 Powers of Suppliers
8.6.4 Bargaining Power of Buyers
8.6.5 Threat of Substitutes
9. Research Interviews from Our Survey
9.1 Mr. Timothy Earle, Chief Operating Officer / Chief Business Officer, TauRx Pharmaceuticals Ltd
9.1.1 Alzheimer’s Treatment in Late Stage Development
9.1.2 Alzheimer’s Severe Under diagnosis
9.1.3 The Benefits of Alzheimer’s Diagnosis: A Future Prospect
9.1.4 Alzheimer’s Treatment: The Greatest Challenge
9.2 Kevin Hrusovsky, Executive Chairman and CEO, Quanterix
9.2.1 Ultra Sensitive Automated Immunoassay Platform for Alzheimer’s
9.2.2 Alzheimer’s Disease Diagnosis Biomarkers
9.2.3 Quanterix: Future Developments
9.3 The Alzheimer’s Association Northern California and Northern Nevada
9.3.1 Alzheimer’s Treatment in Late Stage Development
9.3.2 Novel Biomarkers: Critical for Alzheimer’s Diagnosis
9.3.3 A Push to Improve the Success of Alzheimer’s Research
10. Conclusion
10.1 Novel Diagnostic Technologies Will Emerge First and Then the Disease Modifying Drugs
10.2 Disease Modifying Drugs Will Transform the Declining Alzheimer’s Market
10.3 Demographics Will Help Drive the Market Over the Forecast Period
10.4 Medicines and Diagnostic Tests for Alzheimer’s Disease Hold Great Potential from 2015 to 2026
10.5 Research for Alzheimer’s Happening all Over the World
【レポート販売概要】
■ タイトル：アルツハイマー病治療・診断の世界市場予測2016-2026■ 英文：Alzheimer’s Disease Therapeutics and Diagnostics Market Forecast 2016-2026
■ 発行日：2016年5月
■ 調査会社：visiongain
■ 商品コード：VGAIN60625
■ 調査対象地域：グローバル
- ラケットスポーツ用品の世界市場2017-2021：テニスラケット、バドミントンラケット、スカッシュラケットAbout Racket Sports EquipmentOf the three racket sports discussed in this report, tennis has the highest participation rates. The sale of tennis equipment is related to the number of tennis players and their frequency of playing. Owing to an increase in the number of participants in several small and big tournaments, and an increase in the number of frequent players, the demand for tennis equipmen …
- Vasculitis：グローバル臨床試験レビューH1, 2013Vasculitis Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, “Vasculitis Global Clinical Trials Review, H1, 2013" provides data on the Vasculitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Vasculitis. It includes an overview of the trial numbers and their recruitment status as per the site of tri …
- ロンワークスビル管理システムの世界市場展望2017-20276According to Stratistics MRC, the Global LonWorks Building Management System Market is expected to grow at a CAGR of 17.2% during the forecast period. The market is propelling due to rising demand for energy-efficient and eco-friendly buildings. However, high implementation costs is restraining the market. Based on the type, software helps building operators or homeowners to continuously monitor a …
- 分散アンテナシステム（DAS）の世界市場2016-2020About Distributed Antenna Systems DAS or distributed antenna systems are components that are used to boost cellular network coverage to deal with dead spots or isolated spots of poor coverage. These isolated or dead spots are mostly in large buildings, especially in closed locations, where the cellular network is the weakest. DAS are installed as a network of a large number of small antennas insta …
- 屋上緑化の世界市場2018-2022101 pages, November 2018 About this market The integration of green roofs with photovoltaic arrays are called bio solar roofs. By adding a renewable energy component to green roofs, biosolar roofs help to minimize greenhouse gas emissions as well as ensure sustainable building development. The photovoltaic panels protect the plants from excessive sunlight and water evaporation, whereas the evapotr …
- パーソナル潤滑剤の世界市場2015-2019About personal lubricants Personal lubricants are liquids or gels that women or their partners apply during sexual intercourse and masturbation to reduce friction, enhance pleasure, or reduce pain. Personal lubricants are also commonly used as a remedy for vaginal dryness. It is considered to be the easiest and most effective method of overcoming dryness and chafing during sex. It can be applied t …
- VRFシステム（冷媒流量可変型システム）の世界市場予測（～2023年）：ヒートポンプ、熱回収、屋外ユニット、屋内ユニット、制御装置、付属品The VRF system market is expected to grow from USD 10.04 Billion in 2016 to USD 22.79 Billion by 2023, at a CAGR of 12.43% between 2017 and 2023. The major factors driving the growth of VRF system market include the growing construction industry and easing of norms of FDI for construction and real estate sectors, high energy saving potential as well as easy and minimum maintenance of VRF system, t …
- エネルギークラウドソリューションの世界市場予測（～2021年）The energy cloud market is expected to grow from USD 5.12 Billion in 2016 to USD 15.18 Billion by 2021, at a Compound Annual Growth Rate (CAGR) of 24.3% during the forecast period. The demand for the market is driven by factors, such as rising aging infrastructure and grid security concerns. The growing need for enterprises to have Customer Relationship Management (CRM) is fueling the growth of th …
- 消費者向けエンドポイントセキュリティソフトウェアの世界市場2016-2020About Consumer Endpoint Security Endpoint security refers to the protection of the corporate network when accessed remotely from devices such as laptops, PCs, tablets, and smartphones. Endpoint security mainly consists of two components; security software and client software. While security software is centrally located, and is installed on the server, within the network, client software is instal …
- 水性塗料の世界市場：樹脂別（アクリル、ポリウレタン、エポキシ、アルキド、ポリエステル、PTFE、PVDC、PVDF、その他）、用途別、地域別、セグメント予測The global waterborne coatings market is projected to reach USD 82.9 billion by 2025, according to a new report by Grand View Research, Inc. The market is projected to expand at CAGR of 5.7% over the forecast period. The prices of raw materials used in manufacturing waterborne coatings are expected to have a significant impact on the production cost of the final product. The demand for these raw m …
- 自動車リモートキーレスエントリシステムの世界市場2017-2021About Automotive Remote Keyless Entry System RKE systems were the first form of keyless entry technology introduced in automobiles. An RKE system consists of a key fob that is equipped with a transmitter, which communicates with the vehicle through radio frequency. The receiver installed in the vehicle captures the signal, decodes it, and then instructs the vehicle door to lock or unlock. The key …
- Ostomy Drainage Bags Market to 2019 – Technical Advances Increase Patient Convenience but Unfavorable Reimbursement Scenarios Limit Growth PotentialOstomy Drainage Bags Market to 2019 - Technical Advances Increase Patient Convenience but Unfavorable Reimbursement Scenarios Limit Growth Potential Summary GBI Research’s report, “Ostomy Drainage Bags Market to 2019 - Technical Advances Increase Patient Convenience but Unfavorable Reimbursement Scenarios Limit Growth Potential” looks at the market, key market players, and market dynamics for the …
- スパッタコーティングの世界市場予測Sputtering is the thin film deposition manufacturing process at the core of today’s semiconductors, disk drives, CDs, and optical devices industries. It is a physical vapour deposition process for depositing thin films. Sputtering means ejecting materials from a target and depositing it on a substrate, such as a silicon wafer, display panel, and optical film. The target is the source material whic …
- 静脈イルミネーターの世界市場分析：技術別（透照法、赤外線技術、超音波）、用途別（静脈内アクセス、採血）、エンドユーザー別（病院、リハビリ施設、献血キャンプ、学術機関）、地域別（アメリカ、カナダ、ドイツ、英国、中国、インド、南アフリカ、サウジアラビア、ブラジル、メキシコ）、セグメント予測The global vein illuminator market is expected to reach USD 358.5 million by 2024, according to a new report published by Grand View Research, Inc. The vein illuminator market is anticipated to witness a lucrative growth during the period 2016 to 2024. The factors contributing towards the growth of the market are the growing aging population and the efforts channelized towards improving patient sa …
- 耐熱樹脂の世界市場予測（～2026）：種類別（エポキシ、シリコーン、アクリル、ポリエステル、 ポリエーテルスルホン、アルキド、ポリウレタン、フェノール類、ポリエーテルアミド）、用途別、地域別The global high temperature resin market is estimated to reach USD 4.88 Billion by 2026, at a CAGR of 4.44% from 2016 to 2026. The increasing demand for the high temperature resin as an alternative to mechanical fasteners in high end applications, growth in application areas, increasing demand for high temperature composite resins in railway and aerospace interior applications, and the increasing …
